at pϽ0.05 for AA. We then did a multivariate stratified analysis of WC using sex and ethnicity-specific median cut points. Among those with smaller WC, PA and PA/PRA each were associated with HTN in AA (pϽ.05) where as in FC, PA was not associated with HTN. The risk for HTN in FC increased as PRA increased (ORϭ3.3;. AA with increasing PRA and FC with increasing PA/PRA were at lower risk for HTN (pϽ0.05). There was no significant association of PA, PRA or PA/PRA with HTN in those with larger WC. These results demonstrate that the risk for HTN in AA with smaller WC is influenced directly by the level of PA and inversely by the level of PRA. In contrast, the risk of HTN in FC with smaller WC is directly related to the level of PRA and independent of the level of PA. These findings are relevant to ethnic differences in effectiveness of agents that affect the renin-angiotensinaldosterone system (RAAS) and add to the evidence for ethnic variations in role of the RAAS in the pathophysiology of HTN. Salt sensitivity (SS) is associated with an elevated risk of developing hypertension (HTN) and is an independent risk factor for cardiovascular (CV) morbidity and mortality. Cross-sectional studies have suggested that postmenopausal women are more salt sensitive than premenopausal women. The purpose of the present study was to investigate prospectively the prevalence of SS among healthy premenopausal women and determine whether the loss of ovarian hormones increases SS. We enrolled 40 normotensive (SBP 127Ϯ2, DBP 78Ϯ1; MeanϮSEM), non-diabetic women (age 47Ϯ0.6) undergoing hysterectomy and ovariectomy for non-neoplastic processes to determine the effect of changes in sodium intake on blood pressure (BP) the day before and 4 months after surgical menopause. After a 1-week diet containing 120 mmol/day NaCl, salt loading was achieved with a 2 L infusion of normal saline, followed by salt depletion produced by 40 mg of IV furosemide. A decrease of 10 mmHg in SBP between salt loading and salt depletion was used to define SS. Premenopausal salt sensitive women exhibited higher waist/hip ratio (0.85Ϯ0.017 vs. 0.82Ϯ0.007; pϭ0.001), fasting glucose (105.9Ϯ2.9 vs. 98.5Ϯ3.1 mg/dl; pϭ0.03), triglycerides (155Ϯ35 vs. 90Ϯ6 mg/dl; pϽ0.0001), and microalbuminuria (20.2Ϯ7.3 vs. 4.5Ϯ1.4 mg/24hr; pϽ0.0001) than saltresistant women. Four months after surgical menopause, none of the women were on hormone replacement and all remained normotensive (SBP 127Ϯ3, DBP 77Ϯ2). However, the prevalence of SS was significantly higher after menopause (21 women, 52.5%) than before (9 women, 22.5%, pϭ0.01), because 12 (38.7%) salt resistant women developed SS after menopause. Thus, we found that the prevalence of SS doubled as early as 4 months after surgical menopause, due to the development of SS in previously salt resistant women. The women who developed SS did not manifest an increase in BP or in the above markers of CV risk. However, epidemiological studies indicate that, in most women, development of HTN does not occur until 5-10 years after menopause. We surmise that the loss of ovarian hormones unmasks a population of women prone to SS that with aging would be at higher risk for the development of HTN and its associated CV morbidity and mortality.
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Loss of Ovarian Hormones Increases Salt-Sensitivity in Normotensive Women
Salt sensitivity (SS) is associated with an elevated risk of developing hypertension (HTN) and is an independent risk factor for cardiovascular (CV) morbidity and mortality. Cross-sectional studies have suggested that postmenopausal women are more salt sensitive than premenopausal women. The purpose of the present study was to investigate prospectively the prevalence of SS among healthy premenopausal women and determine whether the loss of ovarian hormones increases SS. We enrolled 40 normotensive (SBP 127Ϯ2, DBP 78Ϯ1; MeanϮSEM), non-diabetic women (age 47Ϯ0.6) undergoing hysterectomy and ovariectomy for non-neoplastic processes to determine the effect of changes in sodium intake on blood pressure (BP) the day before and 4 months after surgical menopause. After a 1-week diet containing 120 mmol/day NaCl, salt loading was achieved with a 2 L infusion of normal saline, followed by salt depletion produced by 40 mg of IV furosemide. A decrease of 10 mmHg in SBP between salt loading and salt depletion was used to define SS. Premenopausal salt sensitive women exhibited higher waist/hip ratio (0.85Ϯ0.017 vs. 0.82Ϯ0.007; pϭ0.001), fasting glucose (105.9Ϯ2.9 vs. 98.5Ϯ3.1 mg/dl; pϭ0.03), triglycerides (155Ϯ35 vs. 90Ϯ6 mg/dl; pϽ0.0001), and microalbuminuria (20.2Ϯ7.3 vs. 4.5Ϯ1.4 mg/24hr; pϽ0.0001) than saltresistant women. Four months after surgical menopause, none of the women were on hormone replacement and all remained normotensive (SBP 127Ϯ3, DBP 77Ϯ2). However, the prevalence of SS was significantly higher after menopause (21 women, 52.5%) than before (9 women, 22.5%, pϭ0.01), because 12 (38.7%) salt resistant women developed SS after menopause. Thus, we found that the prevalence of SS doubled as early as 4 months after surgical menopause, due to the development of SS in previously salt resistant women. The women who developed SS did not manifest an increase in BP or in the above markers of CV risk. However, epidemiological studies indicate that, in most women, development of HTN does not occur until 5-10 years after menopause. We surmise that the loss of ovarian hormones unmasks a population of women prone to SS that with aging would be at higher risk for the development of HTN and its associated CV morbidity and mortality.
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Non-Narcotic Analgesic Dose and Risk of Incident Hypertension in US Women
John P Forman, Meir J Stampfer, Gary C Curhan; Brigham and Women's Hosp, Boston, MA Background: Acetaminophen, ibuprofen, and aspirin are the most commonly used drugs in the United States. Prior studies indicate that the use of these drugs, particularly non-steroidal anti-inflammatory drugs (NSAIDs), may increase the risk of hypertension. However, information on the association between average daily dose and risk of hypertension is unknown. Methods: To determine the independent association between the doses of these drugs and the risk of incident hypertension, we conducted two prospective cohort studies among older women from the Nurses' Health Study I aged 51-77 (nϭ1,903) and younger women from the Nurses' Health Study II aged 34 -53 (nϭ3,220) who completed detailed supplemental questionnaires pertaining to their analgesic use and who did not have hypertension at baseline. We analyzed self-reported incident hypertension according to categories of average daily dose of acetaminophen, non-steroidal anti-inflammatory drugs, and aspirin. Information on indications for analgesic use as well as relevant confounders was also gathered prospectively. Results: Compared to women who did not use acetaminophen, the multivariable adjusted relative risk (RR) for those who took Ͼ 500 mg/d was 1.74 (1.14 -2.63) among older women and 2.00 (1.40 -2.86) among younger women. For non-steroidal anti-inflammatory drugs, similar comparisons yielded multivariable RRs of 1.74 (1.12-2.72) among older women and 1.57 (1.07-2.30) among younger women. There were no significant associations between aspirin dose and incident hypertension. The associations remained significant for dose of acetaminophen and non-steroidal anti-inflammatory drugs among women who did not report headache. Conclusion: Higher daily doses of acetaminophen and NSAIDs increase the risk of hypertension in women. Because acetaminophen and NSAIDs are commonly used, they may contribute to the high prevalence of hypertension in the United States.
P189 Bradykinin Receptor Antagonism Attenuates Protamine-Induced Hypotension Following Cardiopulmonary Bypass
Mias Pretorius, Frank G Scholl, Vanderbilt Univ Sch of Medicine and TN Valley Healthcare System, Nashville, TN; Julie A McFarlane, Laine J Murphey, Nancy J Brown; Vanderbilt Univ Sch of Medicine, Nashville, TN Background: The administration of protamine to heparinized patients following cardiopulmonary bypass (CPB) induces hypotension. Protamine inhibits the carboxypeptidase N-mediated degradation of the vasodilatory peptide bradykinin. This study tests the hypothesis that bradykinin mediates protamine-induced hypotension through its B 2 receptor. Methods: We conducted a prospective, double-blind, randomized study in sixteen adult male patients undergoing elective cardiac surgery requiring CPB and taking an angiotensin-converting enzyme inhibitor preoperatively. Subjects were randomized to receive either saline (Nϭ8) or the bradykinin B 2 receptor antagonist HOE 140 (100g/kg, Nϭ8) prior to the administration of protamine. Mean arterial pressure (MAP) and tissue-type plasminogen activator (t-PA) activity were measured intraoperatively and before and after protamine. Results: Protamine increased bradykinin concentrations from 6.3Ϯ1.1 to 12.1Ϯ2.4 fmol/ml (Pϭ0.015). HOE 140 administration did not affect MAP prior to the administration of protamine. Protamine significantly decreased MAP in the saline group (from 69.8Ϯ4.4 to a mean individual nadir of 56.1Ϯ2.6 mmHg, Pϭ0.031) but bradykinin receptor antagonism blunted this effect (from 74.3Ϯ3.7 to a mean individual nadir of 69.6Ϯ1.2 mmHg in the HOE 140 group, Pϭ0.545). Hence, during protamine infusion, MAP was significantly lower in the saline group compared to the HOE 140 group (Pϭ0.002). T-PA activity decreased significantly during HOE 140 administration (from 3.59Ϯ0.31 to 1.67Ϯ0.42 IU/ml, Pϭ0.001), but not during saline (from 2.12Ϯ0.48 to 1.44Ϯ0.36 IU/ml, Pϭ0.214). Similarly, t-PA activity decreased significantly during protamine administration in the HOE 140 group (from 1.67Ϯ0.42 to 0.77Ϯ0.26 IU/ml, Pϭ0.038), but not in the saline group (from 1.44Ϯ0.36 to 0.99Ϯ0.26 IU/ml, Pϭ0.132). Interpretation: Increased bradykinin contributes to protamine-induced hypotension through its B 2 receptor. Administration of a bradykinin receptor antagonist may represent a novel therapy for the prevention of protamine-induced hypotension.
P190 Clonidine Unmasks Residual Sympathetic Tone Driving Supine Hypertension and Pressure Natriuresis in Autonomic Failure
Cyndya Shibao, Alfredo Gamboa, Satish R Raj, André Diedrich, Robert Abraham, Bonnie K Black, David Robertson, Italo Biaggioni; Vanderbilt Univ, Nashville, TN Supine hypertension is a common finding in autonomic failure, is associated with end organ damage, and produces night-time natriuresis with worsening of orthostatic hypotension (OH). Vasodilators effectively reduce blood pressure (BP) but not natriuresis, nor improve morning OH. We hypothesize that residual sympathetic tone contributes to supine hypertension, and that clonidine would reduce BP and nocturnal natriuresis. We determined the effect of clonidine 0.1mg or transdermal nitroglycerin 0.1 mg/hr, and placebo in 22 patients with primary autonomic failure and supine hypertension (systolic/diastolic BP 180Ϯ5/93Ϯ2 supine, 79Ϯ4/52Ϯ3 mm Hg standing). Medications were given at 8:00 pm and BP recorded every 2 hrs for 12 hrs. The maximal decrease in BP was similar with clonidine and nitroglycerin (-30Ϯ9 and -30Ϯ8 mmHg respectively), as was the average fall in BP throughout the night (Figure) . The decrease in BP induced by clonidine was modestly but significantly correlated with the magnitude of residual sympathetic tone determined in 11 subjects by the fall in BP induced by ganglionic blockade (r 2 ϭ0.4, pϽ0.05). Only clonidine effectively reduced nocturnal natriuresis (pϽ0.05 vs. placebo, Figure) but did not improve morning OH. These results are consistent with residual sympathetic tone contributing to supine hypertension in autonomic failure, which can be targeted with clonidine to decrease blood pressure and nocturnal natriuresis.
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Osteopontin and Plasminogen Activator Inhibitor-1 in Malignant Hypertension: Suppression by p38 MAPK Inhibitors Sandhya S Nerurkar, Alan R Olzinski, Kendall S Frazier, Rosanna C Mirabile, Shawn P O'Brien, Leli Sarov-Blat, Tian-Li Yue, Robert N Willette; GlaxoSmithKline, King Of Prussia, PA Assessment of target organ damage is important in defining optimal treatment of hypertension and blood pressure-related cardiovascular disease. The aims of the present study were to: 1) investigate candidate biomarkers of target organ damage, osteopontin (OPN) and plasminogen
